EZElisa™纤溶酶原激活物抑制剂2（SERPINB2）E
LISA试剂盒-EZElisa™ Plasminogen activator Inhibitor 2 (SERPINB2) ELISA Kit- 询价
- Biogradetech
- 美国
- A-QEK05384-96wells
- 2025年12月03日
企业认证
相关产品推荐更多 >
EZElisa™ Bovine Interferon Alpha（IFNA）ELISA试剂盒-EZElisa™ Bovine Interferon Alpha (IFNa) ELISA Kit
询价
EZElisa™人前列腺素D2合酶,脑（PGD2S）ELISA试剂盒-EZElisa™ Human Prostaglandin D2 Synthase, Brain (PGD2S) ELISA Kit
询价EZElisa™小鼠Fermitin家族同源物3（Fermt3）ELISA试剂盒-EZElisa™ Mouse Fermitin family homolog 3 (Fermt3) ELISA Kit
询价
EZElisa™ Rat Neurookine A（NKA）ELISA试剂盒-EZElisa™ Rat Neurokinin A (NKA) ELISA Kit
询价
EZElisa™人补体成分5a受体1（C5aR1）ELISA试剂盒-EZElisa™ Human Complement Component 5a Receptor 1 (C5aR1) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Plasminogen activator Inhibitor 2 (SERPINB2) ELISA Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™纤溶酶原激活物抑制剂2（SERPINB2）ELISA试剂盒，EZElisa™ Plasminogen activator Inhibitor 2 (SERPINB2) ELISA Kit，纤溶酶原激活物抑制剂2（SERPINB2）ELISA试剂盒, Plasminogen activator Inhibitor 2 (SERPINB2) ELISA Kit
产品名称：EZElisa Serpin B12（SERPINB 12）ELISA试剂盒-EZElisa™ Plasminogen activator Inhibitor 2 (SERPINB2) ELISA Kit
产品货号：A-QEK05384-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of Plasminogen activator Inhibitor 2 (SERPINB2) ELISA in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：
该EZElisa™纤溶酶原激活物抑制剂2（SERPINB2）ELISA试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa Serpin B12（SERPINB 12）ELISA试剂盒-EZElisa™ Plasminogen activator Inhibitor 2 (SERPINB2) ELISA Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene
attachments. One such enzyme, the serine protease urokinase-type plasminogen activator (uPA), converts enzymatically inactive plasminogen into the widely acting protease plasmin, which degrades several extracellular matrix components and also activates
The determination of the protein content of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer tissue extracts is used clinically to identify patients at risk to experience disease recurrence (metastasis
has been on the activities of the serine protease urokinase plasminogen activator (uPA) (1 -4 ), and the matrix metalloproteinases (MMP) (5 ,6 ). The cysteine proteases, such as cathepsin B, and aspartic proteases, such as cathepsin D, also play a role in invasive-ness
技术资料暂无技术资料 索取技术资料
